Laman UtamaABCL • NASDAQ
add
AbCellera Biologics Inc
Tutup sebelumnya
$2.45
Julat tahun
$1.89 - $4.34
Permodalan pasaran
730.07J USD
Bilangan Purata
4.09J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 5.05J | -44.98% |
Perbelanjaan pengendalian | -271.00K | -101.02% |
Pendapatan bersih | -34.21J | 27.44% |
Margin untung bersih | -677.43 | -31.88% |
Pendapatan bagi setiap syer | -0.12 | 25.00% |
EBITDA | -26.04J | 55.50% |
Kadar cukai berkesan | 26.95% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 625.61J | -17.75% |
Jumlah aset | 1.36B | -8.57% |
Jumlah liabiliti | 304.47J | -9.32% |
Jumlah ekuiti | 1.06B | — |
Syer tertunggak | 297.99J | — |
Harga kepada buku | 0.69 | — |
Pulangan pada aset | -7.40% | — |
Pulangan pada modal | -8.97% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -34.21J | 27.44% |
Tunai daripada operasi | -8.00J | 59.21% |
Tunai daripada pelaburan | 35.70J | 246.79% |
Tunai daripada pembiayaan | 4.14J | 10.01% |
Perubahan bersih dalam tunai | 29.68J | 175.92% |
Aliran tunai bebas | -72.44J | -28,861.47% |
Perihal
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Diasaskan
2012
Ibu pejabat
Tapak web
Pekerja
596
